Cann American Corp.

OTC: CNNA · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Cloverdale, CA · SonomaCIK 0001368620Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 35

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, listing tenure · ↓ workforce scale, filing timeliness

Methodology →

Revenue TTM

$21

Rev growth YoY (TTM)

-64.9%

Net income (FY)

-$1.7M

Employees

Market cap

$3.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$1.7M-$1.7M2011

Operating income-$2.0M-$2.0M2011

Total assets$1.2M$1.2M2011

Equity$904.4k$904.4k2011

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Cann American Corp. earned -$1.7M in FY2011 net income.

Peers · Healthcare

Alzamend Neuro Inc——bioAffinity Technologies, Inc.31D BioRestorative Therapies, Inc.38D Matinas BioPharma Holdings, Inc.32D

Neighbors

Sonoma →

Keysight Technologies, Inc.$5.4B77B+Exchange Bank (Santa Rosa, CA)$155.6M49D Summit State Bank$58.8M46D Democrasoft Holdings, Inc.$1.2M——

Key facts

CEOJason R. Tucker

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersCloverdale, CA

ExchangeOTC: CNNA

Employees1

IPO date2011-02-14

Latest filings

8-K2023-06-01 8-K2023-05-17 8-K2023-03-24 8-K2023-03-16 8-K2023-02-06 8-K2023-01-27 8-K2023-01-25 8-K2022-11-02

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.